Forsta AP Fonden Sells 300 Shares of Synopsys, Inc. (NASDAQ:SNPS)

Forsta AP Fonden lowered its stake in Synopsys, Inc. (NASDAQ:SNPS) by 0.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 32,100 shares of the semiconductor company’s stock after selling 300 shares during the period. Forsta AP Fonden’s holdings in Synopsys were worth $13,766,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in SNPS. Advisors Capital Management LLC boosted its stake in Synopsys by 2.3% in the 4th quarter. Advisors Capital Management LLC now owns 840 shares of the semiconductor company’s stock worth $408,000 after purchasing an additional 19 shares during the period. Peninsula Wealth LLC boosted its stake in Synopsys by 0.5% in the 4th quarter. Peninsula Wealth LLC now owns 4,224 shares of the semiconductor company’s stock worth $2,050,000 after purchasing an additional 20 shares during the period. Williams Jones Wealth Management LLC. boosted its stake in Synopsys by 0.5% in the 4th quarter. Williams Jones Wealth Management LLC. now owns 4,650 shares of the semiconductor company’s stock worth $2,257,000 after purchasing an additional 22 shares during the period. Hardy Reed LLC boosted its stake in Synopsys by 0.7% in the 1st quarter. Hardy Reed LLC now owns 3,290 shares of the semiconductor company’s stock worth $1,411,000 after purchasing an additional 22 shares during the period. Finally, Resurgent Financial Advisors LLC boosted its stake in Synopsys by 2.7% in the 1st quarter. Resurgent Financial Advisors LLC now owns 832 shares of the semiconductor company’s stock worth $357,000 after purchasing an additional 22 shares during the period. Institutional investors own 85.47% of the company’s stock.

Synopsys Stock Performance

NASDAQ:SNPS opened at $619.42 on Friday. The stock’s fifty day moving average is $544.48 and its 200 day moving average is $495.09. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The firm has a market capitalization of $96.11 billion, a PE ratio of 44.72, a PEG ratio of 4.10 and a beta of 1.15. The company has a debt-to-equity ratio of 1.01, a quick ratio of 6.85 and a current ratio of 7.02.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $3.40 by $0.27. Synopsys had a return on equity of 17.09% and a net margin of 34.77%. The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.60 billion. During the same quarter in the prior year, the firm posted $3.00 EPS. Synopsys’s quarterly revenue was up 10.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Insider Activity at Synopsys

In other Synopsys news, CRO Richard S. Mahoney sold 9,010 shares of the stock in a transaction on Wednesday, June 18th. The stock was sold at an average price of $471.21, for a total value of $4,245,602.10. Following the sale, the executive owned 1,485 shares in the company, valued at $699,746.85. This trade represents a 85.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $457.93, for a total value of $5,204,832.38. Following the completion of the sale, the chief executive officer owned 71,589 shares in the company, valued at approximately $32,782,750.77. The trade was a 13.70% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 27,686 shares of company stock worth $13,001,048. Company insiders own 0.62% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on SNPS. Rosenblatt Securities upped their price target on Synopsys from $625.00 to $650.00 and gave the stock a “buy” rating in a research note on Friday, July 25th. KeyCorp upped their price objective on Synopsys from $540.00 to $610.00 and gave the stock an “overweight” rating in a report on Thursday, July 10th. Mizuho decreased their price objective on Synopsys from $650.00 to $600.00 and set an “outperform” rating on the stock in a report on Tuesday, April 15th. Needham & Company LLC reaffirmed a “buy” rating and set a $660.00 price objective (up from $650.00) on shares of Synopsys in a report on Tuesday, July 15th. Finally, Stifel Nicolaus set a $550.00 price objective on Synopsys in a report on Monday, April 28th. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $622.33.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.